Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice

Journal of Ethnopharmacology

Volumn 31, Issue 1, 1991, Pages 75-83

  Nair, Satish C ^a   Salomi, M J ^a   Panikkae, Beena ^a   Panikkar, K R ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CROCUS SATIVUS EXTRACT; HEMOGLOBIN; NIGELLA SATIVA EXTRACT; PLANT EXTRACT; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG TOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LIFESPAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMAL; BLOOD UREA NITROGEN; BODY WEIGHT; CISPLATIN; HEMOGLOBINS; INJECTIONS, INTRAPERITONEAL; LEUKOCYTE COUNT; MALE; MICE; PLANT EXTRACTS; SUPPORT, NON-U.S. GOV'T;

EID: 0025956720     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-8741(91)90146-5     Document Type: Article

References (21)

1. Dexamethasone and high dose efficacy in controlling cisplatin-induced nausea and vomiting
2. Protective effect of sodium-2-mercaptoethane sulfornate on the gastrointestinal toxicity of cis-diamine-dichloro-platinum
3. Cisplatin ten years on
4. Measurement of free circulating cis-diamine-cis-dichloroplatinum (II) in plasma
5. Role of 2-MPG against toxicity of cyclophosphamide in normal and tumour bearing mice
6. Inhibition of cisplatin nephrotoxicity by diethyl-dithio carbamate rescue in a rat model
7. Cisplatin nephrotoxicity: The effect of dose, schedule and hydrations scheme
8. Clinical and pharmacological studies with cis-dichloro-diamine-dichloroplatinum (II)
9. Modification of the bone marrow toxicity of cis-diamine-dichloroplatinum (II) in mice by diethyldithiocarbamate
10. Cancer biochemistry
11. Aqueous platinum (II) chemistry, binding to biological molecules
12. Protective effect of S-2-(3-amino propylamino ethyl) phosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice
13. Effect of tumour type, size and end point on tumour protection by WR-2721
14. Rationale for initial clinical trials and future development of radioprotectors
15. Cis-dichloro-diamineplatinum (II). Acid hydrolysis and isotopic exchange of chloride ligands
16. Reactivity of cis-dichloro-diamine-platinum (II) towards selected neucleophiles
17. Anticancer activity of cisplatin (II) and its relevant chemistry
18. Studies on the nephrotoxicity of cisplatin (II) and related substances
19. Blood and urine urea
20. Pancytopenia, aplastic anemia and “pure red cel” aplasia
21. The role of WR-2721 in radiotherapy and or chemotherapy